Intec Pharma regular Real Value cannot be determined due to lack of data. The prevalent price of Intec Pharma is 1495.0. Based on Macroaxis valuation methodology, the corporation cannot be evaluated at this time. Macroaxis calculates value of Intec Pharma from evaluating the corporation fundamentals such as Price to Book of
805.45X, Return On Asset of (41.22)% and Return On Equity of (98.29)% as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage to acquire undervalued assets and to sell overvalued assets since at some point stocks prices and their ongoing real values will come together.
|Horizon||30 Days Login to change|
Intec Pharma Ltd is considered to be number one stock in price to book category among related companies. It is considered to be number one stock in beta category among related companies . The ratio of Price to Book to Beta for Intec Pharma Ltd is about 781.99
|Price to Book ( times )|
Intec Pharma is Unknown risk asset. Calculation of real value of Intec Pharma is based on 2 months time horizon. Increasing Intec Pharma time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.